Phase II trial of oral vinorelbine in combination with cisplatin in advanced non small cell lung cancer (NSCLC)

被引：0
|
作者：
Garassino, I [1 ]
Campagnoli, E. [1 ]
Cavina, R. [1 ]
Soto, Parra H. J. [1 ]
De Vincenzo, F. [1 ]
Zucali, P. A. [1 ]
Salamina, S. [1 ]
Ceresoli, G. L. [1 ]
Santoro, A. [1 ]
机构：
[1] Ist Clin Humanitas, Dept Med Oncol & Hematol, Milan, Italy
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：XI20 / XI20
页数：1
相关论文
共 50 条
  • [31] Partial substitution of cisplatin with carboplatin in combination with etoposide in advanced non-small cell lung cancer (NSCLC): A multicentric randomised Phase II trial
    Comella, P
    Frasci, G
    Panza, N
    DeCataldis, G
    Cioffi, R
    Curcio, C
    Nicolella, D
    Micillo, E
    Ianniello, GP
    Biondi, E
    Perchard, J
    Comella, G
    LUNG CANCER, 1996, 15 (01) : 103 - 114
  • [32] Interim results of a phase II trial of docetaxel in combination with cisplatin in patients with metastatic or locally advanced non-small cell lung cancer (NSCLC)
    Zalcberg, JR
    Bishop, JF
    Millward, MJ
    Zimet, A
    Laird, J
    Barter, C
    Seward, D
    McKeage, MJ
    Friedlander, ML
    Toner, G
    Berille, J
    Blanc, C
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1084 - 1084
  • [33] ORAL ETOPOSIDE PRECEDING CISPLATIN IN ADVANCED NON SMALL CELL LUNG-CANCER (NSCLC) - A PHASE-II STUDY
    FOCAN, C
    VANDERMOTEN, G
    BOOSSY, J
    SCHALLIER, D
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (09): : 1515 - 1520
  • [34] OPEN-LABEL, RANDOMISED MULTICENTRE, PHASE II TRIAL OF ORAL VINORELBINE (NVBO) OR INTRAVENOUS VINORELBINE (NVBIV) WITH CISPLATIN (CDDP) IN PATIENTS (PTS) WITH ADVANCED NON SMALL CELL LUNG CANCER (NSCLC): A CHINESE EXPERIENCE
    Zhang, Li
    Chang Jianhua
    Huang, Cheng
    Wang, Jie
    Shu Yongqian
    Zhang, Yiping
    Burillon, Jean-Philippe
    Pouget, Jean-Christophe
    Riggi, Marcello
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1167 - S1167
  • [35] Phase I/II trial of paclitaxel and vinorelbine in advanced non-small cell lung cancer
    Grunberg, SM
    Dugan, MC
    Greenblatt, MS
    Ospina, DJ
    Valentine, JW
    CANCER INVESTIGATION, 2005, 23 (05) : 392 - 398
  • [36] A phase II trial of combination of CPT-11 and cisplatin for advanced non-small-cell lung cancer
    N Masuda
    M Fukuoka
    A Fujita
    Y Kurita
    S Tsuchiya
    K Nagao
    S Negoro
    H Nishikawa
    N Katakami
    K Nakagawa
    H Niitani
    British Journal of Cancer, 1998, 78 : 251 - 256
  • [37] Phase II trial of docetaxel and vinorelbine in patients with advanced non-small-cell lung cancer
    Miller, VA
    Krug, LM
    Ng, KK
    Pizzo, B
    Perez, W
    Heelan, RT
    Kris, MG
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (06) : 1346 - 1350
  • [38] A phase II trial of the combination of gemcitabine, ifosfamide and cisplatin in the treatment of advanced non-small cell lung cancer
    Vadell-Nadal, C
    Nogué-Aliguer, M
    Fabregat-Mayol, X
    Saigí-Grau, E
    Gallén-Castillo, M
    LUNG CANCER, 2000, 28 (02) : 109 - 115
  • [39] A phase II trial of combination of CPT-11 and cisplatin for advanced non-small-cell lung cancer
    Masuda, N
    Fukuoka, M
    Fujita, A
    Kurita, Y
    Tsuchiya, S
    Nagao, K
    Negoro, S
    Nishikawa, H
    Katakami, N
    Nakagawa, K
    Niitani, H
    BRITISH JOURNAL OF CANCER, 1998, 78 (02) : 251 - 256
  • [40] Vinorelbine/gemcitabine in advanced non-small-cell lung cancer: an AASLC phase II trial
    Krajnik, G
    Malayeri, R
    Thaler, J
    Mohn-Staudner, A
    Greil, R
    Schmeikal, S
    Marhold, F
    Deutsch, J
    Preiss, P
    Zoechbauer-Mueller, S
    Huber, H
    Pirker, R
    17TH INTERNATIONAL CANCER CONGRESS, VOL 1 AND 2, 1998, : 647 - 649
12345